Patent details

Basic Information

Publication number:

EP1266006

PCT Application Number:

PCT/EP/2001/003220

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019277698

PCT Publication Number:

WO/2001/070968

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PRODUCTION OF RECOMBINANT MUTEINS OF BLOOD CLOTTING FACTOR VIII IN HUMAN CELL LINES

French Title of Invention:

PRODUCTION DE MUTEINES RECOMBINANTES DU FACTEUR DE COAGULATION SANGUINE VIII DANS DES LIGNEES DE CELLULES HUMAINES

German Title of Invention:

HERSTELLUNG VON REKOMBINANTEN MUTEINE DES BLUTGERINNUNGSFAKTORS VIII IN HUMANEN ZELLINIEN

SPC Number:

Dates

Filing date:

21/03/2001

Grant date:

07/12/2005

EP Publication Date:

07/12/2005

PCT Publication Date:

27/09/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/12/2002

EP B1 Publication Date:

07/12/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/03/2007

Expiration date:

21/03/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/12/2005

 

 

Name:

Octagene GmbH

Address:

Am Klopferspitz 19, 82152 Martinsried, Germany (DE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

07/12/2005

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

HÖRSTER Andrea

Address:

Germany (DE)

2

Name:

LEHNERER Michael

Address:

Germany (DE)

3

Name:

SCHRÖDER Carola

Address:

Germany (DE)

4

Name:

HAUSER Charlotte

Address:

Germany (DE)

Priority

1

Priority Number:

00106225

Priority Date:

22/03/2000

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

203249 P

Priority Date:

08/05/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 15/12;

Filing date	Document type	Number of pages